During the past decade, Gesundheitszentrum St. Marien GmbH conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gesundheitszentrum St. Marien GmbH" #1 sponsor was "University Hospital Tuebingen" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Ludwig-Maximilians - University of Munich" with 1 trials sponsored and "PD Dr Markus Möhler" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gesundheitszentrum St. Marien GmbH" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gesundheitszentrum St. Marien GmbH" are "Metastatic Breast Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Pancreatic Ductal" (1 trials). Many other conditions were trialed in "Gesundheitszentrum St. Marien GmbH" in a lesser frequency.

Most popular intervention types in "Gesundheitszentrum St. Marien GmbH" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Lenalidomide" (2 trials), "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gesundheitszentrum St. Marien GmbH" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gesundheitszentrum St. Marien GmbH". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gesundheitszentrum St. Marien GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gesundheitszentrum St. Marien GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".